Michigan Medicine Study Links Sotagliflozin to Lower Clot Risk
Researchers discover how the FDA-approved diabetes medication inhibits platelet activation to reduce blood clot formation.
Live Poll
Should medical research prioritize discovering cardiovascular benefits in existing FDA-approved medications?